Nov 09, 2009

Anti-Malignancy Agent Avastin^®
Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer

Home
About Chugai
News
Anti-Malignancy Agent Avastin® Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer

You are now moving to an external website.